Skip to main content

Aptivus Dosage

Generic name: TIPRANAVIR 250mg
Dosage form: capsule, liquid filled, oral solution
Drug class: Protease inhibitors

Medically reviewed by Drugs.com. Last updated on Apr 10, 2024.

Dosage and Administration Overview

APTIVUS must be co-administered with ritonavir to exert its therapeutic effect. Failure to correctly co-administer APTIVUS with ritonavir will result in plasma levels of tipranavir that will be insufficient to achieve the desired antiviral effect and will alter some drug interactions [see Warnings and Precautions (5.1)].

  • Children should be assessed for their ability to swallow capsules before prescribing APTIVUS capsules [see Use in Specific Populations (8.4)].
  • APTIVUS co-administered with ritonavir tablets must only be taken with meals [see Clinical Pharmacology (12.3)].
  • APTIVUS is supplied as capsules. APTIVUS capsules must be swallowed whole and must not be opened or chewed.
  • Due to the need for co-administration of APTIVUS with ritonavir, please refer to the ritonavir prescribing information.

Recommended Dosage in Adults and Pediatric Patients Weighing 36 kg or Higher

The recommended dosage in adults and pediatric patients weighing 36 kg or higher is 500 mg (two 250 mg capsules) of APTIVUS co-administered with 200 mg of ritonavir, twice daily.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.